CStone Pharmaceuticals (CStone Pharmaceuticals) Current Accrued Expense : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is CStone Pharmaceuticals Current Accrued Expense?

CStone Pharmaceuticals's Current Accrued Expense for the quarter that ended in Jun. 2023 was $0.00 Mil.

CStone Pharmaceuticals Current Accrued Expense Historical Data

The historical data trend for CStone Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Current Accrued Expense Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial									-	-	-	-	-

CStone Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

CStone Pharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (CStone Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (OTCPK:CSPHF) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

02616:Hong Kong PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.